XOMA Royalty (XOMA) EBITDA Margin (2011 - 2026)
XOMA Royalty (XOMA) reported EBITDA Margin of 3.87% for Q1 2026, down 15217.0% on a YoY basis from N/an in Q1 2025, and down 124.38% sequentially from 15.88% in Q4 2025.
XOMA Royalty (XOMA) EBITDA Margin (2011 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 16 years of EBITDA Margin data on file, last reported at 3.87% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 15217.0% year-over-year to 3.87%; the trailing twelve-month figure through Mar 2026 stood at 34.89% (up 19654.0% YoY), and the FY2025 full-year result was 21.85%, up 62284.0% from the prior year.
- EBITDA Margin fell to 3.87% in Q1 2026, from 15.88% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 148.3% in Q1 2025 to a low of 2572.0% in Q3 2023.
- A 5-year average of 722.56% and a median of 414.61% in 2024 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin sank 1591309 bps in 2022 and soared 235473 bps in 2024, its largest moves.
- Tracing XOMA's EBITDA Margin over 5 years: stood at 730.59% in 2022, then tumbled by 110 bps to 1533.38% in 2023, then rose by 5 bps to 1450.2% in 2024, then soared by 101 bps to 15.88% in 2025, then sank by 124 bps to 3.87% in 2026.
- Business Quant data shows XOMA's EBITDA Margin at 3.87% in Q1 2026, 15.88% in Q4 2025, and 91.66% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | -3.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.87% |
| Dec 31, 2025 | 15.88% |
| Jun 30, 2025 | 91.66% |
| Mar 31, 2025 | 148.30% |
| Dec 31, 2024 | -1,450.20% |
| Sep 30, 2024 | -217.27% |
| Jun 30, 2024 | -200.52% |
| Mar 31, 2024 | -469.93% |
| Dec 31, 2023 | -1,533.38% |
| Sep 30, 2023 | -2,572.00% |
| Jun 30, 2023 | -359.29% |
| Mar 31, 2023 | -2,327.23% |
| Dec 31, 2022 | -730.59% |
| Sep 30, 2022 | -969.40% |
| Jun 30, 2022 | -908.00% |
| Mar 31, 2022 | -75.09% |
| Dec 31, 2021 | 15,182.50% |
| Sep 30, 2021 | -608.18% |
| Jun 30, 2021 | -340.07% |
| Mar 31, 2021 | -1,713.87% |